Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2025 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2025 Earnings Call Transcript November 12, 2025

Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.46.

Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals third quarter 2025 financial results and business update conference call. At this time, all participants are in listen-only mode. Following the formal remarks, we will open the call up for your questions. I would...